1/12
08:10 am
tmdx
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
Low
Report
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
1/8
07:11 am
tmdx
Is Now The Time To Put TransMedics Group (NASDAQ:TMDX) On Your Watchlist? [Yahoo! Finance]
Low
Report
Is Now The Time To Put TransMedics Group (NASDAQ:TMDX) On Your Watchlist? [Yahoo! Finance]
12/30
04:10 pm
tmdx
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/30
04:05 pm
tmdx
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/28
01:08 am
tmdx
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
Low
Report
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at
Wall Street
12/24
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/24
12:30 am
tmdx
TransMedics Group: I Estimate A Large Upside By The End Of 2028 [Seeking Alpha]
Low
Report
TransMedics Group: I Estimate A Large Upside By The End Of 2028 [Seeking Alpha]
12/23
01:42 pm
tmdx
Why TransMedics Group, Inc. (NASDAQ:TMDX) Looks Like A Quality Company [Yahoo! Finance]
Low
Report
Why TransMedics Group, Inc. (NASDAQ:TMDX) Looks Like A Quality Company [Yahoo! Finance]
12/23
09:09 am
tmdx
TransMedics: A Stagnant Monopoly Facing Regulatory Pressure [Seeking Alpha]
Low
Report
TransMedics: A Stagnant Monopoly Facing Regulatory Pressure [Seeking Alpha]
12/22
10:03 am
tmdx
TransMedics Group (NASDAQ:TMDX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
TransMedics Group (NASDAQ:TMDX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
12/20
01:30 am
tmdx
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at
Wall Stree
Low
Report
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at
Wall Stree
12/17
03:27 pm
tmdx
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $147.00 to $148.00. They now have a "buy" rating on the stock.
Low
Report
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $147.00 to $148.00. They now have a "buy" rating on the stock.
12/8
08:07 am
tmdx
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Needham & Company LLC from $148.00 to $166.00. They now have a "buy" rating on the stock.
Low
Report
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Needham & Company LLC from $148.00 to $166.00. They now have a "buy" rating on the stock.
12/2
01:20 pm
tmdx
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Morgan Stanley from $123.00 to $135.00. They now have an "equal weight" rating on the stock.
Low
Report
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Morgan Stanley from $123.00 to $135.00. They now have an "equal weight" rating on the stock.
11/18
04:05 pm
tmdx
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
High
Report
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
10/31
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10/30
09:46 am
tmdx
TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.
Low
Report
TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.
10/30
08:07 am
tmdx
TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Medium
Report
TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
10/30
06:04 am
tmdx
TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
High
Report
TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
10/29
04:05 pm
tmdx
TransMedics Reports Third Quarter 2025 Financial Results
High
Report
TransMedics Reports Third Quarter 2025 Financial Results
10/23
07:21 am
tmdx
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $148.00 price target on the stock.
Medium
Report
TransMedics Group (NASDAQ:TMDX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $148.00 price target on the stock.